Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes

Details for Australian Patent Application No. 2004253479 (hide)

Owner MannKind Corporation

Inventors Bot, Adrian Ion; Smith, Kent Andrew; Liu, Xiping

Agent Davies Collison Cave

Pub. Number AU-B-2004253479

PCT Pub. Number WO2005/002621

Priority 60/479,393 17.06.03 US

Filing date 17 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 1 September 2011

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/002621 Priority application(s): WO2005/002621

1 September 2011 Application Accepted

  Published as AU-B-2004253479

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253480-Shaving apparatus

2004253478-Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases